About

Name

Lawrence Korngut

University

University of Calgary

Website

http://www.ucalgary.ca/dcns/neurology/members/Korngut

Email

[email protected]

Research Keywords

ALS, phase 2 and 3 clinical trials of new therapies for neuromuscular conditions, Principal Investigator of the Neuromuscular Disease Registry

Most Cited Publications

Mah JK, Korngut L, Dykeman J, Day L, Pringsheim T, Jette N, "A systematic review and meta-analysis on the epidemiology of Duchenne and Becker muscular dystrophy." Neuromuscular disorders : NMD 24,6 (2014 Jun): 482-91
Li G, Sajobi TT, Menon BK, Korngut L, Lowerison M, James M, Wilton SB, Williamson T, Gill S, Drogos LL, Smith EE, Vohra S, Hill MD, Thabane L, 2016 Symposium on Registry-Based Randomized Controlled Trials in Calgary., "Registry-based randomized controlled trials- what are the advantages, challenges, and areas for future research?" Journal of clinical epidemiology 80, (2016 Dec): 16-24
Koeks Z, Bladen CL, Salgado D, van Zwet E, Pogoryelova O, McMacken G, Monges S, Foncuberta ME, Kekou K, Kosma K, Dawkins H, Lamont L, Bellgard MI, Roy AJ, Chamova T, Guergueltcheva V, Chan S, Korngut L, Campbell C, Dai Y, Wang J, Barišić N, Brabec P, Lähdetie J, Walter MC, Schreiber-Katz O, Karcagi V, Garami M, Herczegfalvi A, Viswanathan V, Bayat F, Buccella F, Ferlini A, Kimura E, van den Bergen JC, Rodrigues M, Roxburgh R, Lusakowska A, Kostera-Pruszczyk A, Santos R, Neagu E, Artemieva S, Rasic VM, Vojinovic D, Posada M, Bloetzer C, Klein A, Díaz-Manera J, Gallardo E, Karaduman AA, Oznur T, Topaloğlu H, El Sherif R, Stringer A, Shatillo AV, Martin AS, Peay HL, Kirschner J, Flanigan KM, Straub V, Bushby K, Béroud C, Verschuuren JJ, Lochmüller H, "Clinical Outcomes in Duchenne Muscular Dystrophy: A Study of 5345 Patients from the TREAT-NMD DMD Global Database." Journal of neuromuscular diseases 4,4 (2017): 293-306